A5012516666- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Blood Coagulation and Thrombosis Mechanisms
- Coagulation, Bradykinin, Polyphosphates, and Angioedema
- Cardiac tumors and thrombi
- Hemophilia Treatment and Research
- Cardiac Arrhythmias and Treatments
- Cardiovascular Issues in Pregnancy
- Acute Ischemic Stroke Management
- Acute Myocardial Infarction Research
- Diagnosis and Treatment of Venous Diseases
- Ultrasound in Clinical Applications
- Urticaria and Related Conditions
- Frailty in Older Adults
- Takotsubo Cardiomyopathy and Associated Phenomena
- Radiation Dose and Imaging
- Heart Failure Treatment and Management
- Nutrition and Health in Aging
- Mast cells and histamine
- Vascular Procedures and Complications
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Pericarditis and Cardiac Tamponade
- Infective Endocarditis Diagnosis and Management
University of Insubria
2022-2025
Optimal duration of anticoagulant therapy for left ventricular thrombous (LVT) is unclear. The aim this study to evaluate effectiveness and safety vitamin K antagonists (VKAs) up 12 months in patients with LVT. Patients diagnosed LVT between 2011 2023 treated VKAs until resolution or were enrolled a retrospective cohort study. Primary outcome included on-treatment resolution, secondary outcomes acute ischemic stroke, myocardial infarction, peripheral embolism, major clinically relevant...
Venous thromboembolism (VTE) is a common complication in patients hospitalized for acute medical illnesses. Therefore, inpatients require careful VTE and bleeding risk assessment to drive optimal strategies prevention. Low molecular weight heparin fondaparinux have long been used inhospital prophylaxis at increased of VTE. The selection who post-discharge prophylaxis, the role direct oral anticoagulants remain debated. New molecules currently under development may contribute improve benefit...
Download This Paper Open PDF in Browser Add to My Library Share: Permalink Using these links will ensure access this page indefinitely Copy URL DOI
Abstract Background The optimal duration of anticoagulant therapy to achieve thrombus resolution and prevent cardioembolic events in left ventricular thrombosis (LVT) has not yet been established. Purpose purpose our study is evaluate the incidence LVT at 3 versus 12 months vitamin K antagonists (VKAs) therapy. Methods Consecutive patients diagnosed with treated VKAs for least 5 outpatient clinics Italy were retrospectively included. primary effectiveness outcome was on-treatment while...